Amid Swine Flu, Sales Of Antiviral Drugs Surging; Swine Flu Is Sweet Pill For Roche And GlaxoSmithKline
Published: May 05, 2009
Pharmaceutical Business Review -- GlaxoSmithKline's Relenza and Roche's Tamiflu, two of the most controversial medicines of 2002 have caught the limelight after the out break of swine flu. World Health Organization (WHO) quoted: "It has become clear that containment of the swine flu outbreak is no longer feasible." WHO has raised the alert level from 3 to 4, which signifies that the virus is potential for outbreak at community level. The tourists have been urged not to set foot on Mexican soil.